ASLAN Pharmaceuticals (ASLN) Reports Q3 Loss of $0.78
Tweet
Share
E-mailGet Alerts ASLN Hot Sheet
Join SI Premium – FREE
ASLAN Pharmaceuticals (NASDAQ: ASLN) reported Q3 EPS of ($0.78).
For earnings history and earnings-related data on ASLAN Pharmaceuticals (ASLN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
